Abramson, B. L., & Nelson, S. M. (2025). PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events. Canadian Cardiology Today, 1(1), 20–25. https://doi.org/10.58931/cct.2025.114